401
Views
19
CrossRef citations to date
0
Altmetric
In Vitro and Animal Studies

Xanthohumol, a hop-derived prenylflavonoid present in beer, impairs mitochondrial functionality of SW620 colon cancer cells

ORCID Icon, , , &
Pages 396-404 | Received 17 Sep 2018, Accepted 22 Oct 2018, Published online: 20 Nov 2018

References

  • Ansari A, Rahman MS, Saha SK, Saikot FK, Deep A, Kim KH. 2017. Function of the SIRT3 mitochondrial deacetylase in cellular physiology, cancer, and neurodegenerative disease. Aging Cell. 16:4–16.
  • Becker H, Gerhäuser C. 2008. Beer in health and disease prevention. London (UK). Chapter 12, Phenolic compounds in beer; p. 124–144.
  • Bhandari A, Woodhouse M, Gupta S. 2017. Colorectal cancer is a leading cause of cancer incidence and mortality among adults younger than 50 years in the USA: a SEER-based analysis with comparison to other young-onset cancers. J Investig Med. 65:311–315.
  • Birsoy K, Possemato R, Lorbeer FK, Bayraktar EC, Thiru P, Yucel B, Wang T, Chen WW, Clish CB, Sabatini DM, et al. 2014. Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides. Nature. 508:108–112.
  • Blanquer-Rosselló MM, Oliver J, Valle A, Roca P. 2013. Effect of xanthohumol and 8-prenylnaringenin on MCF-7 breast cancer cells oxidative stress and mitochondrial complexes expression. J Cell Biochem. 114:2785–2794.
  • Brenner H, Kloor M, Pox CP. 2014. Colorectal cancer. Lancet. 383:1490–1502.
  • Chung S, Yao H, Caito S, Hwang J, Arunachalam G, Rahman I. 2010. Regulation of SIRT1 in cellular functions: Role of polyphenols. Arch Biochem Biophys. 501:79–90.
  • Callemien D, Jerkovic V, Rozenberg R, Collin S. 2004. Hop as an interesting source of resveratrol for brewers: optimization of the extraction and quantitative study by liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometry. J Agric Food Chem. 53(2):424–429
  • Farinetti A, Zurlo V, Manenti A, Coppi F, Mattioli AV. 2017. Mediterranean diet and colorectal cancer: A systematic review. Nutrition. 43–44:83–88.
  • Fato R, Bergamini C, Bortolus M, Maniero AL, Leoni S, Ohnishi T, Lenaz G. 2009. Differential effects of mitochondrial Complex I inhibitors on production of reactive oxygen species. Biochim Biophys Acta. 1787:384–392.
  • Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. 2015. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386.
  • Finley LWS, Haigis MC. 2012. Metabolic regulation by SIRT3: Implications for tumorigenesis. Trends Mol Med. 18:516–523.
  • Gerhäuser C. 2005. Beer constituents as potential cancer chemopreventive agents. Eur J Cancer. 41:1941–1954.
  • Gorlach S, Fichna J, Lewandowska U. 2015. Polyphenols as mitochondria-targeted anticancer drugs. Cancer Lett. 366:141–149.
  • Greenwell M, Rahman PKSM. 2015. Medicinal Plants: Their Use in Anticancer Treatment. Int J Pharm Sci Res. 6:4103–4112.
  • Grothey A. 2005. Clinical management of oxaliplatin-associated neurotoxicity. Clin Colorectal Cancer. 5:S38–S46.
  • Hammond WA, Swaika A, Mody K. 2016. Pharmacologic resistance in colorectal cancer: a review. Ther Adv Med Oncol. 8:57–84.
  • Heinz S, Freyberger A, Lawrenz B, Schladt L, Schmuck G, Ellinger-Ziegelbauer H. 2017. Mechanistic investigations of the mitochondrial complex i inhibitor rotenone in the context of pharmacological and safety evaluation. Sci Rep. 7:45465.
  • Hudcová T, Bryndová J, Fialová K, Fiala J, Karabín M, Jelínek L, Dostálek P. 2014. Antiproliferative effects of prenylflavonoids from hops on human colon cancer cell lines. J Instit Brew. 120:225–230.
  • Karabin M, Hudcova T, Jelinek L, Dostalek P. 2015. Biotransformations and biological activities of hop flavonoids. Biotechnol Adv. 33:1063–1090.
  • Khazir J, Mir BA, Pilcher L, Riley DL. 2014. Role of plants in anticancer drug discovery. Phytochem Lett. 7:173–181.
  • Kim HS, Quon MJ, Kim JA. 2014. New insights into the mechanisms of polyphenols beyond antioxidant properties; lessons from the green tea polyphenol, epigallocatechin 3-gallate. Redox Biol. 2:187–195.
  • Kirkwood JS, Legette LL, Miranda CL, Jiang Y, Stevens JF. 2013. A metabolomics-driven elucidation of the anti-obesity mechanisms of xanthohumol. J Biol Chem. 288:19000–19013.
  • Koopman WJH, Nijtmans LGJ, Dieteren CEJ, Roestenberg P, Valsecchi F, Smeitink JAM, Willems PHGM. 2010. Mammalian mitochondrial complex i: biogenesis, regulation, and reactive oxygen species generation. Antioxid Redox Signal. 12:1431–1470.
  • Krajnović T, Kaluđerović GN, Wessjohann LA, Mijatović S, Maksimović-Ivanić D. 2016. Versatile antitumor potential of isoxanthohumol: Enhancement of paclitaxel activity in vivo. Pharmacol Res. 105:62–73.
  • Kuipers EJ, Grady WM, Lieberman D, Seufferlein T, Sung JJ, Boelens PG, Velde CJH. v d, Watanabe T. 2015. Colorectal cancer. Nat Rev Dis Primers. 1:15065.
  • la Lastra CA. d, Villegas I. 2007. Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications. Biochem Soc Trans. 35:1156–1160.
  • Li N, Ragheb K, Lawler G, Sturgis J, Rajwa B, Melendez JA, Robinson JP. 2003. Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production. J Biol Chem. 278:8516–8525.
  • Mcwhirter D, Kitteringham N, Jones RP, Malik H, Park K, Palmer D. 2013. Chemotherapy induced hepatotoxicity in metastatic colorectal cancer: A review of mechanisms and outcomes. Crit Rev Oncol Hematol. 88:404–415.
  • Miranda CL, Stevens JF, Helmrich A, Henderson MC, Rodriguez RJ, Yang YH, Deinzer ML, Barnes DW, Buhler DR. 1999. Antiproliferative and cytotoxic effects of prenylated flavonoids from hops (Humulus lupulus) in human cancer cell lines. Food Chem Toxicol. 37:271–285.
  • Nikolic D, Li Y, Chadwick LR, Pauli GF, Breemen RB. v. 2005. Metabolism of xanthohumol and isoxanthohumol, prenylated flavonoids from hops (Humulus lupulus L.), by human liver microsomes. J Mass Spectrom. 40:289–299.
  • Pan L, Becker H, Gerhäuser C. 2005. Xanthohumol induces apoptosis in cultured 40-16 human colon cancer cells by activation of the death receptor- and mitochondrial pathway. Mol Nutr Food Res. 49:837–843.
  • Panieri E, Santoro MM. 2016. ROS homeostasis and metabolism: a dangerous liason in cancer cells. Cell Death Dis. 7:e2253.
  • Pillai VB, Kanwal A, Fang YH, Sharp WW, Samant S, Arbiser J, Gupta MP. 2017. Honokiol, an activator of Sirtuin-3 (SIRT3) preserves mitochondria and protects the heart from doxorubicin-induced cardiomyopathy in mice. Oncotarget. 8:34082–34098.
  • Ralph SJ, Moreno-Sánchez R, Neuzil J, Rodríguez-Enríquez S. 2011. Inhibitors of succinate: quinone reductase/complex II regulate production of mitochondrial reactive oxygen species and protect normal cells from ischemic damage but induce specific cancer cell death. Pharm Res. 28:2695–2730.
  • Ramos S. 2008. Cancer chemoprevention and chemotherapy: Dietary polyphenols and signalling pathways. Mol Nutr Food Res. 52:507–526.
  • Reczek CR, Chandel NS. 2017. The two faces of reactive oxygen species in cancer. Annu Rev Cancer Biol. 1:79–98.
  • Schwingshackl L, Schwedhelm C, Galbete C, Hoffmann G. 2017. Adherence to Mediterranean diet and risk of cancer: an updated systematic review and meta-analysis. Nutrients. 9:1063.
  • Sporn MB, Liby KT. 2005. Cancer chemoprevention: scientific promise, clinical uncertainty. Nat Clin Pract Oncol. 2:518–525.
  • Stevens JF, Page JE. 2004. Xanthohumol and related prenylflavonoids from hops and beer: to your good health!. Phytochemistry. 65:1317–1330.
  • Stevens JF, Revel JS, Maier CS. 2017. Mitochondria-centric review of polyphenol bioactivity in cancer models. Antioxid Redox Signal: Ars. 2017:7404.
  • Strathmann J, Klimo K, Sauer SW, Okun JG, Prehn JHM, Gerhäuser C. 2010. Xanthohumol-induced transient superoxide anion radical formation triggers cancer cells into apoptosis via a mitochondria-mediated mechanism. FASEB J. 24:2938–2950.
  • Tan X, Wen Q, Wang R, Chen Z. 2017. Chemotherapy-induced neutropenia and the prognosis of colorectal cancer: a meta-analysis of cohort studies. Expert Rev Anticancer Ther. 17:1077–1085.
  • Tang BL. 2016. Sirt1 and the mitochondria. Mol Cells. 39:87–95.
  • Trachootham D, Alexandre J, Huang P. 2009. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?. Nat Rev Drug Discov. 8:579–591.
  • Vellinga TT, Borovski T, Boer VCJ, de Fatrai S, Schelven S, van Trumpi K, Verheem A, Snoeren N, Emmink BL, Koster J, et al. 2015. SIRT1/PGC1α-dependent increase in oxidative phosphorylation supports chemotherapy resistance of colon cancer. Clin Cancer Res. 21:2870–2879.
  • Verdin E, Hirschey MD, Finley LWS, Haigis MC. 2010. Sirtuin regulation of mitochondria: Energy production, apoptosis, and signaling. Trends Biochem Sci. 35:669–675.
  • Wheaton WW, Weinberg SE, Hamanaka RB, Soberanes S, Sullivan LB, Anso E, Glasauer A, Dufour E, Mutlu GM, Budigner GS, et al. 2014. Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis. Elife. 3:e02242.
  • Zhang B, Chu W, Wei P, Liu Y, Wei T. 2015. Xanthohumol induces generation of reactive oxygen species and triggers apoptosis through inhibition of mitochondrial electron transfer chain complex I. Free Radic Biol Med. 89:486–497.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.